Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
kortikotropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
kortikotropiner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Product containing tetracosactide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntropin 250 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntropin 1 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
kortikotropinzinkhydroxidpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Product containing corticotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntropin 50 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotrophins adverse reaction (disorder) |
Causative agent |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotrophins allergy |
Causative agent |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntropin 25 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
kortikotropin 80 enheder/ml i gelatine, injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|